TCC in Transplant Patients
TRANSITIONAL CELL carcinoma (TCC) is the predominant malignancy to develop in Chinese renal transplant recipients, according to researchers at the Capital University of Medical Sciences in Beijing.
Your Email Address:
Recipient(s) Email Address:
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
Include a message (optional):
The e-mail address(es) that you supply to use this service will only be used to send the requested article.